Terms: = Brain cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
469 results:
1. Clinical Management of Patients with Non-Small Cell Lung cancer, brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
3. Real-World treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
4. An Infant-Type Hemispheric Glioma With SOX5::alk: A Novel Fusion.
Tsai CC; Huang MH; Fang CL; Hsieh KL; Hsieh TH; Ho WL; Chang H; Tsai ML; Kao YC; Miser JS; Wong TT; Su MY; Liu YL
J Natl Compr Canc Netw; 2024 Feb; 22(1):. PubMed ID: 38394779
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of Immunohistochemical Expression of alk-1 in Gliomas, WHO Grade 4 and Its Correlation with IDH1-R132H Mutation Status.
Khairy RA; Momtaz EM; Abd El Aziz AM; Shibel PEE
Asian Pac J Cancer Prev; 2024 Jan; 25(1):317-323. PubMed ID: 38285799
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/alk-positive non-small cell lung cancer with brain metastases: a retrospective study.
Qian J; He Z; Wu Y; Li H; Zhang Q; Li X
BMC Cancer; 2024 Jan; 24(1):117. PubMed ID: 38262977
[TBL] [Abstract] [Full Text] [Related]
7. Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-alk and alk-EML4 in combined treatment of Alectinib and CyberKnife: A case report.
Li Y; Lu S; Yao P; Huang W; Huang Y; Zhou Y; Yuan Y; Cheng S; Wu F
Medicine (Baltimore); 2024 Jan; 103(3):e36992. PubMed ID: 38241569
[TBL] [Abstract] [Full Text] [Related]
8. A case of inflammatory myofibroblastic tumor harboring EML4-alk fusion with a brain metastasis responding to alectinib.
Sakoda S; Tanaka K; Koga Y; Mikumo H; Tsuchiya-Kawano Y; Harada E; Tamiya S; Okamoto I
Thorac Cancer; 2024 Feb; 15(5):415-418. PubMed ID: 38213097
[TBL] [Abstract] [Full Text] [Related]
9. Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (alk)-positive lung cancer and multiple brain metastases.
Murakami Y; Kawashima Y; Chiba S; Hara S; Yamazaki Y; Doman T; Saito S; Odaka T; Ogasawara T; Shimizu H; Sugisaka J; Aiba T; Toi Y; Yamanda S; Kimura Y; Sugawara S
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1981. PubMed ID: 38212894
[TBL] [Abstract] [Full Text] [Related]
10. High efficacy of brigatinib for brain metastases in alk fusion gene-positive non-small cell lung cancer: A case series.
Morikawa K; Numata Y; Shinozaki Y; Kaneko S; Matsushima A; Nishida M; Kida H; Handa H; Nishine H; Mineshita M
Thorac Cancer; 2024 Feb; 15(6):496-499. PubMed ID: 38158887
[TBL] [Abstract] [Full Text] [Related]
11. In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non-small-cell Lung cancer.
Schoenmaekers J; Dijkstra J; van der Wekken A; Paats M; Broen M; Brandts L; Dingemans AM; Hendriks L
Clin Lung Cancer; 2024 Mar; 25(2):168-174.e1. PubMed ID: 38151408
[TBL] [Abstract] [Full Text] [Related]
12. Case report: Successful sequential therapy of crizotinb and entrectinib in ROS1-positive non-small-cell lung cancer with brain metastasis in later-settings.
Dong W; Zhuge J; Yu P; Liu K; Yang M; Wang H
Medicine (Baltimore); 2023 Dec; 102(51):e36591. PubMed ID: 38134118
[TBL] [Abstract] [Full Text] [Related]
13. Management strategies for intracranial progression in alk-positive non-small cell lung cancer: a real-world cohort study.
Shen CI; Chiang CL; Huang HC; Tseng YH; Luo YH; Yang HC; Chen YM
J Neurooncol; 2023 Dec; 165(3):459-465. PubMed ID: 38051455
[TBL] [Abstract] [Full Text] [Related]
14. Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung cancer: An Italian Expert Panel Discussion.
Gridelli C; Tiseo M; Cortinovis DL; Migliorino MR; Barbieri V; Bironzo P; Bearz A; Attili I; de Marinis F
Curr Oncol; 2023 Nov; 30(11):10033-10042. PubMed ID: 37999149
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Characteristics of Patients with Advanced alk-Translocated Non-small Cell Lung cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Dhamelincourt E; Descourt R; Rousseau-Bussac G; Doubre H; Decroisette C; Demontrond P; Le Garff G; Falchero L; Huchot E; Vieillot S; Corre R; Kazulinski L; Bizieux A; Bigay-Gamé L; Morel H; Molinier O; Chouaïd C; Guisier F
Target Oncol; 2023 Nov; 18(6):905-914. PubMed ID: 37966566
[TBL] [Abstract] [Full Text] [Related]
16. Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome.
Hong W; Zhang T; Shan C; Li H; Lin T; Liu D; Zhen J; Li J; Lai M; Zhou Z; Zhou C; Zhou M; Wang M; Cai L; Wen L
BMC Cancer; 2023 Nov; 23(1):1096. PubMed ID: 37950224
[TBL] [Abstract] [Full Text] [Related]
17. Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial Tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression.
Pflug KM; Lee DW; Tripathi A; Bankaitis VA; Burgess K; Sitcheran R
Mol Pharm; 2023 Dec; 20(12):6140-6150. PubMed ID: 37939020
[TBL] [Abstract] [Full Text] [Related]
18. Transformation of NSCLC to SCLC harboring EML4-alk fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review.
Lingling X; Maoxi C; Wei Y; Jieting Z; Yuanyuan Y; Ning X
Lung Cancer; 2023 Dec; 186():107415. PubMed ID: 37907052
[TBL] [Abstract] [Full Text] [Related]
19. Clinical outcomes of
Hansen KH; Johansen JS; Urbanska EM; Meldgaard P; Hjorth-Hansen P; Kristiansen C; Stelmach M; Santoni-Rugiu E; Ulhøi MP; Dydensborg AB; Dünweber C; Andersen JL
Acta Oncol; 2023 Dec; 62(12):1775-1783. PubMed ID: 37815923
[TBL] [Abstract] [Full Text] [Related]
20. Frailty indices in patients undergoing surgical resection of brain metastases: a systematic review.
Roy JM; Bangash AH; Skandalakis GP; Bowers CA
Neurosurg Rev; 2023 Oct; 46(1):267. PubMed ID: 37815634
[TBL] [Abstract] [Full Text] [Related]
[Next]
